Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ICON Public Limited Company    ICLR   IE0005711209

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ICON PUBLIC LIMITED COMPAN
02/19/20 FY 2019 Earnings Release (Projected)
04/29/20 Q1 2020 Earnings Release (Projected)
07/22/20 Interim 2020 Earnings Release (Projected)
Past events on ICON PUBLIC LIMITED COMPAN
09/05/19 | 01:25pm Baird Global Healthcare Conference
07/25/19 | 10:00am Interim 2019 Earnings Call
07/25/19 International Drug Discovery Science & Technology Congress
07/24/19 | 04:15pm Interim 2019 Earnings Release
Upcoming sector events for ICON PUBLIC LIMITED COMPAN
10/24/19 GALAPAGOS NV : Q3 2019 Earnings Release
10/24/19 BIO-TECHNE CORP : Annual General Meeting
10/25/19 | 08:00am GALAPAGOS NV : Q3 2019 Earnings Call
10/28/19 CHARLES RIVER LABORATORIES INTL. INC : Q3 2019 Earnings Release (Projected)
More events
Past sector events for ICON PUBLIC LIMITED COMPAN
09/29/19 | 06:00am INCYTE CORPORATION : European Society for Medical Oncology Congress - Abstract #2078
09/29/19 | 10:54am INCYTE CORPORATION : European Society for Medical Oncology Congress - Abstract #1621
10/07/19 | 09:30am ALNYLAM PHARMACEUTICALS, INC. : Investor Meeting - Givosiran, in Development for the Treatment of Acute Hepatic Porphyria
10/10/19 | 11:30am ALNYLAM PHARMACEUTICALS, INC. : Investor Meeting - Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1
Annual publications
Annual results2016201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread
1 666
1 672
-0,35%
1 758
1 759
-0,01%
2 596
2 592
0,13%

2 813

3 032

3 263
Operating income
(EBITDA)
M $
Released
Forecast
Spread
379
380
-0,11%
407
406
0,37%
452
454
-0,39%

495

543

590
Operating profit
(EBIT)
M $
Released
Forecast
Spread
320
318
0,43%
346
343
0,79%
386
384
0,49%

432

479

527
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
300
303
-0,98%
328
328
0,10%
365
364
0,29%

423

468

515
Net income
M $
Released
Forecast
Spread
262
260
0,93%
281
288
-2,4%
323
322
0,29%

372

412

454
EPS
 $
Released
Forecast
Spread
4,65
4,61
0,80%
5,13
5,25
-2,4%
5,89
5,90
-0,13%

6,87

7,66

8,43
Announcement Date02/16/201702/15/201802/20/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise